Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID06716450

Study to Evaluate Accuracy, Usability, and Readability of the Multiplo TP/HIV Antibody Self-Test and Peer-led HIV and Syphilis Care in People Experiencing Homelessness in Toronto

Led by Unity Health Toronto · Updated on 2026-01-27

900

Participants Needed

3

Research Sites

36 weeks

Total Duration

On this page

Sponsors

U

Unity Health Toronto

Lead Sponsor

U

University of Toronto

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the Multiplo TP/HIV Self-Test to identify HIV and syphilis infections among people in Canada, especially aiming to reach those undiagnosed. This study investigates whether untrained individuals can accurately perform this self-test, which is designed to provide quick results from a fingerstick blood sample. The test is under review for use by trained healthcare professionals, while this study explores its use as a self-test by lay persons. Participants will use the Multiplo TP/HIV Self-Test on their own without prior training, following only written instructions. A trained observer will watch and record their testing process and independently interpret the self-test results. About 400 participants will also interpret ten mock test devices showing various results to assess their ability to read test outcomes. All participants will provide venous blood samples for laboratory testing with standard HIV and syphilis tests to compare accuracy. During the study, participants will complete questionnaires about the test's usability and clarity of instructions. They will return for a follow-up visit about two weeks later to receive their laboratory test results. The study measures how well the self-test agrees with laboratory results and evaluates participants' understanding and interpretation of test results. Safety and suitability will be monitored, and counselling may be provided if reactive results are found. Total study participation involves initial testing and a follow-up visit approximately two weeks later.

CONDITIONS

Brief Title

Multiplo Tp/HIV Self-Test

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Are 18 years of age or older
  • Can speak, read, and write English or French
  • Have presented for voluntary HIV and/or syphilis testing in clinic or community settings
  • Are willing to participate in standard HIV and syphilis counselling and testing programs
  • Are willing to participate in the study
  • Can provide informed consent
  • Can complete required testing on the assigned day
  • Are willing to provide fingerstick and venipuncture blood samples for study testing
  • Have unknown HIV and syphilis status (last negative test at least 3 months ago)
Not Eligible

You will not qualify if you...

  • Do not meet the inclusion criteria
  • Are known HIV and/or syphilis positive
  • Have ever tested positive for HIV or syphilis
  • Have experience conducting rapid point-of-care tests for HIV, syphilis, or other infectious diseases
  • Are familiar with the Multiplo TP/HIV Self-Test
  • Are employees or immediate family of study investigators or sponsors
  • Have participated in prior or concurrent HIV and syphilis self-test trials
  • Are practicing healthcare professionals performing HIV rapid tests
  • Have any condition making participation unsafe or unsuitable, such as inability to read, intoxication, acute sickness, or visible distress

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (in-person)

Diagnostic Evaluation

Duration - 1 day

Participants perform the Multiplo TP/HIV Self-Test and provide venous blood samples for laboratory testing to determine HIV and syphilis status. Participants also complete questionnaires about usability and label comprehension. Some participants interpret mock test results.

1 visit (in-person)

Long-term Monitoring

Duration - Approximately 2 weeks after initial testing

Participants return to the clinic approximately two weeks later to receive their laboratory test results and may receive counselling or treatment as needed.

1 follow-up visit (in-person)

Trial Site Locations

Total: 3 locations

1

Cool Aid Community Health Centre

Victoria, British Columbia, Canada, V8W 1M8

Actively Recruiting

2

Hassle Free Clinic

Toronto, Ontario, Canada, M5B 1G3

Actively Recruiting

3

Women's Health in Women's Hands

Toronto, Ontario, Canada, M5B 1J3

Actively Recruiting

Loading map...

Research Team

M

Megan Cedrone, BSc, MSc

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Similar Trials

#AWARE.HIV Europe: Supporting Healthcare Professionals to Fi...

HIV Infection

Actively Recruiting

28 locations

A Study to Evaluate the Performance, Usability, and Contrive...

HIV 1 Infection

Actively Recruiting

3 locations

Cardiovascular Risk in Children With Chronic Conditions Stud...

Kidney Transplant

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Is Theory Guiding Our Work? A Scoping Review on the Use of Implementation Theories, Frameworks, and Models to Bring Community Health Workers into Health Care Settings.

Caitlin G Allen, Colleen Barbero, Sharada Shantharam...

https://pubmed.ncbi.nlm.nih.gov/30180116

What do we know about community-based health worker programs? A systematic review of existing reviews on community health workers.

Kerry Scott, S W Beckham, Margaret Gross...

https://pubmed.ncbi.nlm.nih.gov/30115074